Jacobs Levy Equity Management Inc. Has $11.31 Million Stock Holdings in Trupanion, Inc. $TRUP

Jacobs Levy Equity Management Inc. increased its holdings in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 2,029.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 303,550 shares of the financial services provider's stock after purchasing an additional 289,292 shares during the period. Jacobs Levy Equity Management Inc. owned approximately 0.71% of Trupanion worth $11,313,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of the business. AlphaQuest LLC increased its stake in Trupanion by 940.6% during the 1st quarter. AlphaQuest LLC now owns 1,051 shares of the financial services provider's stock worth $39,000 after purchasing an additional 950 shares in the last quarter. PNC Financial Services Group Inc. increased its position in shares of Trupanion by 11.8% during the first quarter. PNC Financial Services Group Inc. now owns 2,234 shares of the financial services provider's stock worth $83,000 after acquiring an additional 235 shares in the last quarter. Occudo Quantitative Strategies LP acquired a new stake in shares of Trupanion during the fourth quarter worth $227,000. Gotham Asset Management LLC acquired a new stake in shares of Trupanion during the fourth quarter worth $234,000. Finally, Y Intercept Hong Kong Ltd bought a new stake in Trupanion in the 1st quarter valued at $243,000.

Trupanion Stock Up 0.2%

Shares of NASDAQ:TRUP traded up $0.10 during midday trading on Friday, reaching $43.56. The company had a trading volume of 263,278 shares, compared to its average volume of 586,549. Trupanion, Inc. has a 1-year low of $31.00 and a 1-year high of $57.90. The stock has a market cap of $1.87 billion, a PE ratio of 167.56 and a beta of 1.72. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.32. The business's 50 day moving average price is $48.17 and its 200 day moving average price is $44.11.

Trupanion (NASDAQ:TRUP - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The financial services provider reported $0.22 earnings per share for the quarter, beating analysts' consensus estimates of ($0.03) by $0.25. Trupanion had a return on equity of 3.31% and a net margin of 0.81%.The firm had revenue of $353.56 million during the quarter, compared to the consensus estimate of $346.73 million. During the same period last year, the company earned ($0.14) earnings per share. The business's revenue was up 12.3% compared to the same quarter last year. Trupanion has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Research analysts forecast that Trupanion, Inc. will post 0.13 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have issued reports on the company. Cantor Fitzgerald upgraded Trupanion to a "hold" rating in a report on Wednesday, August 13th. Stifel Nicolaus upped their price objective on Trupanion from $41.00 to $45.00 and gave the stock a "hold" rating in a research report on Friday, August 8th. Finally, Piper Sandler increased their price objective on Trupanion from $62.00 to $67.00 and gave the stock an "overweight" rating in a report on Friday, August 8th. Three research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company's stock. According to data from MarketBeat.com, Trupanion currently has a consensus rating of "Moderate Buy" and an average target price of $54.17.

Insider Buying and Selling at Trupanion

In other news, Director Darryl Rawlings sold 30,369 shares of the business's stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $44.70, for a total transaction of $1,357,494.30. Following the transaction, the director directly owned 1,413,281 shares in the company, valued at $63,173,660.70. The trade was a 2.10% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Fawwad Qureshi sold 2,800 shares of the firm's stock in a transaction dated Tuesday, August 26th. The shares were sold at an average price of $45.56, for a total transaction of $127,568.00. Following the completion of the sale, the chief financial officer owned 6,451 shares of the company's stock, valued at $293,907.56. This trade represents a 30.27% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 52,800 shares of company stock worth $2,364,335 over the last ninety days. Insiders own 5.42% of the company's stock.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.